Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge after Freezing
Pharmaceutical Technology in Hospital Pharmacy · 2017
DOI: 10.1515/pthp-2016-0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Technology in Hospital Pharmacy, 2017. Verfasst von Clara Balouzet und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Azacitidine is supplied as lyophilized powder to be reconstituted with sterile water for injection. The molecule is very unstable in aqueous medium (temperature-dependent process). Advance preparation and leftover management are made difficult by such poor stability. This study evaluates the stability of 25 mg/mL azacitidine suspensions kept for a 1-month period at –20 °C, followed by a 5-day period at 5 °C. Three batches of 7 polypropylene syringes were filled with 2 mL of Vidaza
Zitieren
APA
Balouzet, C., Chanat, C., Jobard, M., Brandely-Piat, M., & Chast, F. (2017). Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge after Freezing. Pharmaceutical Technology in Hospital Pharmacy. https://doi.org/10.1515/pthp-2016-0023
Vancouver
Balouzet C, Chanat C, Jobard M, Brandely-Piat M, Chast F. Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge after Freezing. Pharmaceutical Technology in Hospital Pharmacy. 2017. doi:10.1515/pthp-2016-0023
BibTeX
@article{Balouzet2017,
author = {Balouzet, Clara and Chanat, Cédric and Jobard, Marion and Brandely-Piat, Marie-Laure and Chast, François},
title = {Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge after Freezing},
journal = {Pharmaceutical Technology in Hospital Pharmacy},
year = {2017},
doi = {10.1515/pthp-2016-0023}
}
EUVIMED